NCT04164732 - Study of Efficacy of Oral Sacubitril/Valsartan in Adult Patients With Non-obstructive Hypertrophic Cardiomyopathy | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 8, 2020

Primary Completion Date

August 22, 2023

Study Completion Date

August 22, 2023

Conditions

Cardiomyopathy, Hypertrophic

Interventions

DRUG

LCZ696

LCZ696 orally twice daily

DRUG

Placebo

placebo

Trial Locations (18)

10789

Novartis Investigative Site, Berlin

20246

Novartis Investigative Site, Hamburg

24105

Novartis Investigative Site, Kiel

28222

Novartis Investigative Site, Madrid

30120

Novartis Investigative Site, El Palmar

46010

Novartis Investigative Site, Valencia

69120

Novartis Investigative Site, Heidelberg

97239

Novartis Investigative Site, Portland

280796

Novartis Investigative Site, Madrid

94305-5826

Novartis Investigative Site, Stanford

02114

Novartis Investigative Site, Boston

48109 5271

Novartis Investigative Site, Ann Arbor

07960

Novartis Investigative Site, Morristown

151 23

Novartis Investigative Site, Athens

711 10

Novartis Investigative Site, Heraklion Crete

03722

Novartis Investigative Site, Seoul

05505

Novartis Investigative Site, Seoul

EC1A 7BE

Novartis Investigative Site, London